Longitudinal evolution of ventricular function and cardiac magnetic resonance imaging tissue characteristics in tafamidis-treated transthyretin amyloid cardiomyopathy

Amyloid. 2024 Jun;31(2):145-147. doi: 10.1080/13506129.2023.2284108. Epub 2023 Dec 9.
No abstract available

MeSH terms

  • Aged
  • Amyloid Neuropathies, Familial* / diagnostic imaging
  • Amyloid Neuropathies, Familial* / drug therapy
  • Amyloid Neuropathies, Familial* / genetics
  • Amyloid Neuropathies, Familial* / metabolism
  • Amyloid Neuropathies, Familial* / pathology
  • Benzoxazoles* / pharmacology
  • Benzoxazoles* / therapeutic use
  • Cardiomyopathies* / diagnostic imaging
  • Cardiomyopathies* / drug therapy
  • Cardiomyopathies* / genetics
  • Cardiomyopathies* / metabolism
  • Cardiomyopathies* / pathology
  • Female
  • Humans
  • Magnetic Resonance Imaging* / methods
  • Male
  • Middle Aged
  • Prealbumin / genetics
  • Prealbumin / metabolism

Substances

  • tafamidis
  • Benzoxazoles
  • Prealbumin

Supplementary concepts

  • Amyloidosis, Hereditary, Transthyretin-Related